OCRF Talk with Lin Zhang, M.D.
OCRF Talk with Lin Zhang, M.D.
In an interview, 3-time grantee Dr. Zhang discusses his research and what it means to receive an award from OCRF.
News
Report from ASCO 2013–What's New in Ovarian Canc...
Report from ASCO 2013–What's New in Ovarian Cancer Research
We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new … Continued
Supreme Court Strikes Down BRCA Gene Patents
Supreme Court Strikes Down BRCA Gene Patents
In a unanimous ruling issued June 13, 2013, the US Supreme Court ruled that private companies do not have the right to patent human genes. In Association for Molecular Pathology et … Continued
June 2013 SNMMI Meeting
June 2013 SNMMI Meeting
Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap … Continued
Press Release: Ovarian Cancer Advocates Praise Supreme Cour...
Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents
Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning … Continued
New Meta-Analysis of Oral Contraception and Risk of Ovarian...
New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer
A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use. See the … Continued
ASCO News: Weekly Chemo Improves Quality of Life
ASCO News: Weekly Chemo Improves Quality of Life
In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively … Continued
ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse
ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse
Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian … Continued
Partner Member Profile: Nine Girls Ask
Partner Member Profile: Nine Girls Ask
Like many women with ovarian cancer, Joan Wyllie was misdiagnosed by multiple doctors before learning she had stage IV ovarian cancer. Once she learned what was causing her symptoms, Joan … Continued
Ovarian Cancer Incidence Fell Along with Hormone Therapy Use
Ovarian Cancer Incidence Fell Along with Hormone Therapy Use
In a study published online in the Journal of Clinical Oncology on May 6, 2013, researchers reported results of a study investigating menopausal hormonal therapy (MHT) use and the incidence … Continued
Decreases in Ovarian Cancer Correlate to Decrease in Use of...
Decreases in Ovarian Cancer Correlate to Decrease in Use of Hormone Replacement Therapy
A new study shows that rates of ovarian cancer decreased around the same time that the use of hormone replacement therapy dropped off. Overall, for women over 50, rates decreased … Continued
Alliance Responds to Angelina Jolie's BRCA1 Announcement
Alliance Responds to Angelina Jolie's BRCA1 Announcement
Actress Angelina Jolie recently announced that she carries a mutation in the BRCA1 gene, which makes her more likely to develop breast and ovarian cancer. In the wake of that … Continued